DR info

Clinical trials : 25 / Drugs : 40 - (DrugBank : 11) / Drug target genes : 22 - Drug target pathways : 20

Angelman syndrome and other diseases between which drug repositioning might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Drug repositionability

ID	Diseases (Sorted by drug repositionability)
201	Angelman syndrome
6	Parkinson disease
2	Amyotrophic lateral sclerosis
17	Multiple system atrophy
140	Dorabe syndrome
8	Huntington disease
152	PCDH19 related syndrome
206	Fragile X syndrome
5	Progressive supranuclear palsy
97	Ulcerative colitis
13	Multiple sclerosis/Neuromyelitis optica
21	Mitochondrial disease
205	Fragile X syndrome related disease
272	Fibrodysplasia ossificans progressiva
145	West syndrome
75	Cushing disease
70	Spinal stenosis
22	Moyamoya disease
155	Acquired aphasia with convulsive disorder
156	Rett syndrome
231	Alpha-1-antitrypsin deficiency
158	Tuberous sclerosis
46	Malignant rheumatoid arthritis
98	Eosinophilic gastrointestinal disease
18	Spinocerebellar degeneration
296	Biliary atresia
36	Epidermolysis bullosa
144	Lennox-Gastaut syndrome
193	Prader-Willi syndrome
298	Hereditary pancreatitis
3	Spinal muscular atrophy
84	Sarcoidosis
34	Neurofibromatosis
96	Crohn disease
7	Corticobasal degeneration
4	Primary lateral sclerosis
164	Oculocutaneous albinism
309	Progressive myoclonus epilepsy
74	Prolactin secreting pituitary adenoma
90	Retinitis pigmentosa
299	Cystic fibrosis